• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对BALB/c小鼠感染的多表位候选疫苗的免疫原性。

Immunogenicity of Multiepitope Vaccine Candidate against Infection in BALB/c Mice.

作者信息

Hajissa Khalid, Zakaria Robaiza, Suppian Rapeah, Mohamed Zeehaida

机构信息

Dept. of Zoology, Faculty of Science and Technology, Omdurman Islamic University, Omdurman, Sudan.

Dept. of Medical Microbiology & Parasitology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Ku-bang Kerian, Kelantan, Malaysia.

出版信息

Iran J Parasitol. 2018 Apr-Jun;13(2):215-224.

PMID:30069205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6068360/
Abstract

BACKGROUND

is a widely prevalent intracellular protozoan parasite which causes serious clinical and veterinary problems. Development of an effective vaccine for controlling toxoplasmosis is an extremely important aim. In the present study, the protective efficacy of recombinant multiepitope antigen (USM.TOXO1) expressing nine potential epitopes identified from SAG1, GRA2, and GRA7 of was evaluated in BALB/c mice.

METHODS

Mice were immunized subcutaneously with three doses of USM.TOXO1 antigen (10 μg/ml). Following the immunization, the IgG antibody, IgG subclass, IFN-γ and IL-4 production were evaluated using ELISA, the study was conducted at Animal Research and Service Center (ARASC), USM Health Campus in 2016.

RESULTS

Mice immunized with USM.TOXO1 significantly induced a mixed Th1/Th2 response polarized toward the IgG1 antibody isotype. While the cytokine analysis revealed a significant release of IFN-γ cytokines.

CONCLUSION

USM.TOXO1 is a potential vaccine candidate that elicits strong immunity in BALB/c mice. The proven immunogenicity of the generated antigen can serve as a premise for further use of epitope-based vaccine in the immunoprevention of human and animal toxoplasmosis.

摘要

背景

是一种广泛流行的细胞内原生动物寄生虫,可引发严重的临床和兽医问题。开发一种有效的控制弓形虫病的疫苗是一个极其重要的目标。在本研究中,在BALB/c小鼠中评估了表达从弓形虫SAG1、GRA2和GRA7中鉴定出的九个潜在表位的重组多表位抗原(USM.TOXO1)的保护效力。

方法

用三剂USM.TOXO1抗原(10μg/ml)对小鼠进行皮下免疫。免疫后,使用ELISA评估IgG抗体、IgG亚类、IFN-γ和IL-4的产生,该研究于2016年在美国玛拉工艺大学健康校区动物研究与服务中心(ARASC)进行。

结果

用USM.TOXO1免疫的小鼠显著诱导了偏向IgG1抗体亚型的混合Th1/Th2反应。而细胞因子分析显示IFN-γ细胞因子有显著释放。

结论

USM.TOXO1是一种潜在的疫苗候选物,可在BALB/c小鼠中引发强大的免疫力。所产生抗原已证实的免疫原性可作为进一步将基于表位的疫苗用于人和动物弓形虫病免疫预防的前提。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1054/6068360/032eabe91af1/IJPA-13-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1054/6068360/3a2d24c0edfd/IJPA-13-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1054/6068360/032eabe91af1/IJPA-13-215-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1054/6068360/3a2d24c0edfd/IJPA-13-215-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1054/6068360/032eabe91af1/IJPA-13-215-g002.jpg

相似文献

1
Immunogenicity of Multiepitope Vaccine Candidate against Infection in BALB/c Mice.针对BALB/c小鼠感染的多表位候选疫苗的免疫原性。
Iran J Parasitol. 2018 Apr-Jun;13(2):215-224.
2
Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of in BALB/c mice.对携带来自RH株的SAG1和GRA7基因的新型双启动子DNA疫苗在BALB/c小鼠中的免疫原性和保护效率进行评估。
Infect Drug Resist. 2019 Aug 15;12:2519-2530. doi: 10.2147/IDR.S209270. eCollection 2019.
3
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.刚地弓形虫:用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.
4
An evaluation of a recombinant multiepitope based antigen for detection of Toxoplasma gondii specific antibodies.一种重组多表位抗原的评估,用于检测弓形虫特异性抗体。
BMC Infect Dis. 2017 Dec 29;17(1):807. doi: 10.1186/s12879-017-2920-9.
5
Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice.评价编码弓形虫表面抗原 1(SAG1)和 14-3-3 蛋白的 DNA 疫苗在 BALB/c 小鼠中诱导的保护性免疫应答。
Parasit Vectors. 2012 Nov 26;5:273. doi: 10.1186/1756-3305-5-273.
6
Immunogenicity and protection efficacy of enhanced fitness recombinant Typhi monovalent and bivalent vaccine strains against acute toxoplasmosis.增强适应力的重组伤寒单价和双价疫苗株对急性弓形虫病的免疫原性和保护效果。
Pathog Glob Health. 2021 Sep;115(6):392-404. doi: 10.1080/20477724.2021.1881369. Epub 2021 Feb 1.
7
Plant Hsp90 is a novel adjuvant that elicits a strong humoral and cellular immune response against B- and T-cell epitopes of a Toxoplasma gondii SAG1 peptide.植物热休克蛋白 90 是一种新型佐剂,能诱导针对弓形虫 SAG1 肽的 B 细胞和 T 细胞表位的强烈体液和细胞免疫应答。
Parasit Vectors. 2019 Mar 25;12(1):140. doi: 10.1186/s13071-019-3362-6.
8
Evaluation of immunogenicity and protective effect of DNA vaccine encoding surface antigen1 (SAG1) of Toxoplasma gondii and TLR-5 ligand as a genetic adjuvant against acute toxoplasmosis in BALB/c mice.评价编码刚地弓形虫表面抗原1(SAG1)的DNA疫苗及作为基因佐剂的TLR-5配体对BALB/c小鼠急性弓形虫病的免疫原性和保护作用。
Biologicals. 2019 Nov;62:39-49. doi: 10.1016/j.biologicals.2019.10.002. Epub 2019 Oct 11.
9
Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.弓形虫 SAG1、SAG3 和 SAG5 免疫原性的计算机设计多表位 DNA 疫苗,佐剂为 CpG-ODN,用于 BALB/c 小鼠急性弓形虫病。
Acta Trop. 2021 Apr;216:105836. doi: 10.1016/j.actatropica.2021.105836. Epub 2021 Jan 21.
10
Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris.刚地弓形虫:在毕赤酵母中表达及鉴定含SAG1和GRA2的重组蛋白
Parasitol Res. 2007 Mar;100(4):829-35. doi: 10.1007/s00436-006-0341-6. Epub 2006 Oct 21.

引用本文的文献

1
Immunoinformatics studies and design of a novel multi-epitope peptide vaccine against based on calcium-dependent protein kinases antigens through an analysis.基于钙依赖性蛋白激酶抗原,通过免疫信息学研究和设计一种新型多表位肽疫苗。
Clin Exp Vaccine Res. 2024 Apr;13(2):146-154. doi: 10.7774/cevr.2024.13.2.146. Epub 2024 Apr 30.
2
Screening of apical membrane antigen-1 (AMA1), dense granule protein-7 (GRA7) and rhoptry protein-16 (ROP16) antigens for a potential vaccine candidate against for chickens.筛选顶膜抗原-1(AMA1)、致密颗粒蛋白-7(GRA7)和棒状体蛋白-16(ROP16)抗原,以寻找一种潜在的鸡用疫苗候选物。
Vaccine X. 2023 Jul 8;14:100347. doi: 10.1016/j.jvacx.2023.100347. eCollection 2023 Aug.
3

本文引用的文献

1
Mixture of Alum--Naloxone and Alum--Naltrexone as a novel adjuvant elicits immune responses for Toxoplasma gondii lysate antigen in BALB /c mice.明矾-纳洛酮与明矾-纳曲酮混合物作为一种新型佐剂可引发BALB/c小鼠对刚地弓形虫裂解物抗原的免疫反应。
Exp Parasitol. 2016 Mar;162:28-34. doi: 10.1016/j.exppara.2016.01.001. Epub 2016 Jan 7.
2
Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice.用重组微线体蛋白进行疫苗接种可使小鼠免受实验性弓形虫病的侵害。
PLoS One. 2015 Nov 17;10(11):e0143087. doi: 10.1371/journal.pone.0143087. eCollection 2015.
3
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.
Designing mRNA- and Peptide-Based Vaccine Construct against Emerging Multidrug-Resistant : A Computational-Based Subtractive Proteomics Approach.
设计针对新兴多药耐药性的基于 mRNA 和肽的疫苗构建体:基于计算的消减蛋白质组学方法。
Medicina (Kaunas). 2022 Sep 27;58(10):1356. doi: 10.3390/medicina58101356.
4
Designing a Multi-Epitope Vaccine against : An Immunoinformatics Approach.设计一种针对[具体疾病或病原体]的多表位疫苗:一种免疫信息学方法。 (你提供的原文中against后缺少具体内容)
Vaccines (Basel). 2022 Aug 25;10(9):1389. doi: 10.3390/vaccines10091389.
5
Development of a Novel Multi-Epitope Vaccine Candidate against Infection in Fish: An Immunoinformatics Study.一种新型抗鱼类感染多表位疫苗候选物的研发:一项免疫信息学研究
Arch Razi Inst. 2022 Feb 28;77(1):45-56. doi: 10.22092/ARI.2021.353377.1601. eCollection 2022 Feb.
6
Execution and Design of an Anti HPIV-1 Vaccine with Multiple Epitopes Triggering Innate and Adaptive Immune Responses: An Immunoinformatic Approach.一种具有多个触发天然免疫和适应性免疫反应表位的抗人副流感病毒1型疫苗的实施与设计:一种免疫信息学方法
Vaccines (Basel). 2022 May 29;10(6):869. doi: 10.3390/vaccines10060869.
7
Construction of A Synthetic Gene Encoding the Multi-Epitope of and Demonstration of the Relevant Recombinant Protein Production: A Vaccine Candidate.编码[具体名称]多表位的合成基因构建及相关重组蛋白表达的验证:一种候选疫苗
Galen Med J. 2020 Jul 20;9:e1708. doi: 10.31661/gmj.v9i0.1708. eCollection 2020.
8
A Review on the Prevalence of in Humans and Animals Reported in Malaysia from 2008-2018.马来西亚 2008-2018 年人类和动物中 流行情况的综述报告。
Int J Environ Res Public Health. 2020 Jul 3;17(13):4809. doi: 10.3390/ijerph17134809.
9
Epitope-based vaccine as a universal vaccination strategy against infection: A mini-review.基于表位的疫苗作为预防感染的通用疫苗接种策略:一篇综述。
J Adv Vet Anim Res. 2019 Mar 24;6(2):174-182. doi: 10.5455/javar.2019.f329. eCollection 2019 Jun.
刚地弓形虫:用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.
4
A Toxoplasma gondii vaccine encoding multistage antigens in conjunction with ubiquitin confers protective immunity to BALB/c mice against parasite infection.一种与泛素结合编码多阶段抗原的弓形虫疫苗赋予BALB/c小鼠针对寄生虫感染的保护性免疫。
Parasit Vectors. 2015 Sep 30;8:498. doi: 10.1186/s13071-015-1108-7.
5
Design and evaluation of a recombinant multi-epitope antigen for serodiagnosis of Toxoplasma gondii infection in humans.用于人类弓形虫感染血清学诊断的重组多表位抗原的设计与评估
Parasit Vectors. 2015 Jun 11;8:315. doi: 10.1186/s13071-015-0932-0.
6
Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.用弓形虫裂解物抗原而非重组蛋白抗原混合物进行初免-加强免疫接种,可减少BALB/c小鼠脑囊肿的形成。
PLoS One. 2015 May 26;10(5):e0126334. doi: 10.1371/journal.pone.0126334. eCollection 2015.
7
Evaluation of an indirect ELISA using recombinant granule antigen GRA1, GRA7 and soluble antigens for serodiagnosis of Toxoplasma gondii infection in chickens.使用重组颗粒抗原GRA1、GRA7和可溶性抗原的间接ELISA法用于鸡弓形虫感染血清学诊断的评估。
Res Vet Sci. 2015 Jun;100:161-4. doi: 10.1016/j.rvsc.2015.04.011. Epub 2015 Apr 28.
8
Epitope analysis, expression and protection of SAG5A vaccine against Toxoplasma gondii.弓形虫SAG5A疫苗的表位分析、表达及免疫保护作用
Acta Trop. 2015 Jun;146:66-72. doi: 10.1016/j.actatropica.2015.03.013. Epub 2015 Mar 16.
9
Protective immunity induced by peptides of AMA1, RON2 and RON4 containing T-and B-cell epitopes via an intranasal route against toxoplasmosis in mice.通过鼻内途径给予含有T细胞和B细胞表位的AMA1、RON2和RON4肽诱导的小鼠抗弓形虫保护性免疫。
Parasit Vectors. 2015 Jan 13;8:15. doi: 10.1186/s13071-015-0636-5.
10
Recent advances in Toxoplasma gondii immunotherapeutics.弓形虫免疫疗法的最新进展。
Korean J Parasitol. 2014 Dec;52(6):581-93. doi: 10.3347/kjp.2014.52.6.581. Epub 2014 Dec 23.